Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
India · Delayed Price · Currency is INR 69.05
-2.95 (-4.10%)
At close: Nov 12, 2026
NSE:AAKAAR Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 979 | 682 | - | - | - | - | |
Market Cap Growth | -10.90% | - | - | - | - | - |
Enterprise Value | 1,157 | 839 | - | - | - | - |
Last Close Price | 69.05 | 48.10 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.92 | 10.27 | - | - | - | - |
PS Ratio | 1.15 | 1.02 | - | - | - | - |
PB Ratio | 1.68 | 1.25 | - | - | - | - |
P/TBV Ratio | 1.71 | 1.26 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.36 | 1.25 | - | - | - | - |
EV/EBITDA Ratio | 7.25 | 8.13 | - | - | - | - |
EV/EBIT Ratio | 7.32 | 8.23 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.33 | 0.34 | 0.98 | 1.20 | 0.61 | 0.44 |
Debt / EBITDA Ratio | 1.18 | 1.80 | 2.32 | 2.96 | 1.59 | 1.55 |
Debt / FCF Ratio | - | - | - | - | - | 34.56 |
Net Debt / Equity Ratio | 0.31 | 0.04 | 0.74 | 1.18 | 0.59 | 0.18 |
Net Debt / EBITDA Ratio | 1.12 | 0.22 | 1.75 | 2.90 | 1.54 | 0.63 |
Net Debt / FCF Ratio | -1.04 | -0.26 | -3.13 | -1.82 | -1.78 | 14.05 |
Asset Turnover | 1.07 | 1.00 | 1.40 | 1.61 | 1.68 | 1.29 |
Inventory Turnover | 1.69 | 1.65 | 1.83 | 1.65 | 1.65 | 1.37 |
Quick Ratio | 1.89 | 2.24 | 1.12 | 0.80 | 0.81 | 1.75 |
Current Ratio | 2.91 | 3.21 | 1.73 | 1.59 | 1.72 | 4.59 |
Return on Equity (ROE) | 20.84% | 17.06% | 33.70% | 25.86% | 23.54% | 22.45% |
Return on Assets (ROA) | 12.37% | 9.54% | 13.72% | 10.80% | 11.58% | 10.15% |
Return on Invested Capital (ROIC) | 15.18% | 15.13% | 21.24% | 17.14% | 19.65% | 19.25% |
Return on Capital Employed (ROCE) | 26.70% | 18.40% | 40.00% | 37.00% | 35.00% | 19.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 11.22% | 9.74% | - | - | - | - |
FCF Yield | -17.53% | -13.11% | - | - | - | - |
Payout Ratio | - | - | - | - | 24.38% | 31.12% |
Buyback Yield / Dilution | -23.76% | -34.81% | -7.84% | -0.19% | -0.26% | - |
Total Shareholder Return | -23.76% | -34.81% | -7.84% | -0.19% | -0.26% | - |